4821/JN/25 - Mobile Clinic Unit Partner for Supporting Community Based Prostate Cancer Screening

Description

The purpose of this procurement exercise is to secure a vehicle based mobile clinic unit partner to support the delivery of Work Package 2 (WP2) within the IMProVE study, with a focus on improving equitable access to prostate cancer screening. The IMProVE study’s full title is “Prostate cancer screening using a risk adapted PSA/image-based approach: Pilot study for a Yorkshire wide comparison with Standard care”. The study is funded by Yorkshire Cancer Research and is being run in collaboration with Queen Mary University of London (QMUL) and the University of Sheffield (study sponsor).<br /><br />WP2 pilots community-based prostate cancer screening in Leeds and Sheffield, combining targeted invitations and community outreach to recruit eligible men for PSA blood testing and optional saliva sampling via vehicle based mobile clinic units. Participants are randomised to either standard NHS care or an image-based pathway, with follow-up diagnostics and referrals managed within the NHS. It is anticipated that 45,000 men will be invited to take part in screening, with uptake estimated to be 4,500 men (10%).<br /><br />This is an open exercise. The ITT can be downloaded by registering and expressing your interest on the University`s e-tendering system https://in-tendhost.co.uk/sheffield<br /><br />If you have any questions or comments in relation to this tender they must be submitted via the In-tend system, this can be accessed at https://in-tendhost.co.uk/sheffield<br /><br />Completed tenders must be returned through the same e-tendering system.<br /><br />The closing date of receipt of tenders: 20th October 2025 at 12 noon (UK time).